Received Apr 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z005055 | — |
No additional AE / No adverse effects were reported.; an expired dose of GARDASIL 9 was inadvertently administered to a 24 yr old female patient today, 4/17/2026; This spontaneous report was received from a medical assistant and refers to a 24-year-old female patient. The patient's medical history, concurrent conditions, past medications and concomitant medications were not reported. On 17-Apr-2026, the patient was vaccinated with Human Papillomavirus 9-Valent Vaccine, Recombinant (GARDASIL 9) (also reported as Gardasil, conflicting information) suspension for injection, 0.5 ml, lot# Z005055, expiration date: 27-Feb-2026 (dose number, route of administration and anatomical location were not reported), for prophylaxis (Expired product administered). Post Expiry Memo supported potency of the dose. No adverse effects, no additional adverse events were reported.